|
btastat.com
| |
The BTA TRAK® Assay
A Powerful New
Quantitative Immunoassay
for Monitoring Bladder Cancer Patients
|
Useful in
Monitoring Patients for
Disease Progression and Recurrence
-
Accurate, non-invasive adjunct to
cystoscopy
-
Superior sensitivity and specificity
-
Serial measurements may aid in
detecting persistent disease following surgical or medical treatment
for bladder cancer
-
The BTA TRAK Assay results may predict
recurrence by detecting tumors not visualized by cystoscopy
|
|
Mean BTA TRAK Assay Values for Healthy Subjects and Bladder Cancer Patients
[Distribution of Bladder tumor antigen by disease state]
| Disease
Category |
Sample
Size (n) |
Mean
(U/mL) |
| Healthy
Subjects |
212 |
4.1 |
| Active
Bladder Cancer* |
216 |
604 |
| Stage:
|
Tis |
18 |
68 |
| |
Ta |
108 |
317 |
| |
T1 |
38 |
851 |
| |
T2-4 |
50 |
1250 |
| Grade:
|
I |
53 |
212 |
| |
II |
56 |
543 |
| |
III |
96 |
914 |
| *(includes
unknown stages/grades) |
|
|
